PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

NCT00911170 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

847

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer
Colon Cancer
Colorectal Cancer
Fever
Locally Advanced
Metastatic Colorectal Cancer
Neutropenia
Rectal Cancer

Interventions

DRUG: Pegfilgrastim
DRUG: Placebo
BIOLOGICAL: Bevacizumab
DRUG: Standard Chemotherapy

Sponsor

Amgen